Phase 2a TREE study assesses safety and efficacy of leriglitazone
News
Orphelia Pharma explores other pathways for paediatric cancer treatment
Company seeks new direction after negative CHMP opinion on KIZFIZO
Dementia drug neflamapimod shows positive phase 2b trial results
CervoMed’s therapy demonstrates significant improvement in patients
New weight-loss pill shows promising results
Oxford Medical Products targets overweight individuals
Agomab announces positive phase 2a interim results for AGMB-129
FSCD therapy meets all endpoints in interim analysis
Pfizer’s Talzenna therapy accepted for use within NHS Scotland
Scottish Medicines Consortium approves new option for mCRPC patients
Leqembi enters second consultation period following NICE draft guidance update
NICE convenes third committee meeting for additional appraisal consideration
NHS patients receive UK-donated plasma medicines for first time in 30 years
Octapharma supports NHS in building resilient supply chain
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements
Centauri therapeutics selects first ABX-01 clinical candidate
Lead candidate for lung infections moves to human trials
Blood cancer patients face treatment access disparity
New research highlights NHS approval gap compared to other cancers
Datapharm collaborates with VIDAL to improve medicines information access in France
New partnership to integrate SRD search technology
Brainomix partners with Medtronic to enhance stroke care
New collaboration aims to integrate AI solutions for treatment
Microbiotica unveils new data on MB097 at AACR IO meeting
Data presented in Los Angeles showcases therapy’s potential
